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Staphylococcus aureus and Staphylococcus pseudointermedius are well recognized as potential pathogens in both 
animal and human medicine. In the present study, oral, nasal and skin swabs were collected from 21 dogs and 2 
cats attended in a Veterinary Hospital in Porto, Portugal, from veterinary practitioners and auxiliary workers 
(hands and nose), and from nine different contact surfaces used by veterinary practitioners, auxiliary workers and 
animals.  
Swabs were cultured in Baird Parker – Rabbit Plasma fibrinogen (Biokar) and incubated at 37oC for 36 hours. 
Subsequently all coagulase-positive Staphylococcus were subcultured onto Chromagar STAPHaureus 
(CHROMAGAR) and then screened for antimicrobial susceptibility.  Polymerase Chain Reaction was performed 
with primers for S. aureus (au-F3, and au-nucR) and S. pseudointermedius (pse-F2, pse-R5,) in order to identify 
the Staphylococcus species. 
All colonies exhibiting typical S. aureus morphology (mauve colour) and all purple-blue coloured colonies were 
identified as S. aureus and S. pseudointermedius, respectively. This procedure has proven to be reliable for S.
pseudointermedius isolation, being an alternative to the laborious and time consuming biochemical tests. 
Among the tested animals, 65.2% (n=15) carried coagulase-positive Staphylococcus: 30.4% (n=7) S. aureus and 
52.2% (n=12) S. pseudointermedius. Two dogs(8.7%)carried methicillin resistant Staphylococcus aureus
(MRSA) and four (17.4%) dogs were colonized with methicillin resistant Staphylococcus pseudointermedius
(MRSP).Antimicrobial resistances to amoxicillin, thrimethropim-sulphamethoxazole and lomefloxacin were the 
most common in MRSP carriers. Four animals carried both S. aureus and S. pseudointermedius from the same 
swabs. In two animals, MRSP isolates presenting more than one antimicrobial resistance profile were found in 
the isolation place. Oral and nasal mucosae were the animal locations where more S. aureus bacteria were 
isolated while S. pseudointermedius were isolated mostly in oral mucosae and skin. 
Among the environment swabs, S. pseudointermedius was isolated from the floor of the Hospital recovery area 
and the computer keyboards, both isolates being MRSP. S. aureus was found only in computers keyboards. 
Regarding the nine veterinary practitioners and auxiliary workers tested, in all hand samples and in 22.2% of the 
nasal swabs, Staphylococcus displaying coagulase positive activity were isolated. Hand isolates consisted of S.
aureus in 88.9% (n=8) and S. pseudointermedius in 55.6% (n=5), one of which was MRSP. Only 22.2% (n=2) 
presented S. aureus in nose samples and none S. pseudointermedius was isolated. 
S. aureus isolated from computer keyboard and veterinary practitioners displayed the same resistance pattern. 
This last fact alerts to the necessity of good hygiene practices such as hand washing, aseptic practices and good 
surface disinfection during all processes of animal management. 
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Bacterial infections caused mainly by P. aeruginosa are typical of cystic fibrosis (CF) lung disease. Despite the 
long and aggressive antibiotic therapy, CF patients still died because of these chronic infections. The deprived 
bacterial eradication is mainly due to several strategies adopted by bacteria to achieve CF airways adaptation and 
tolerance to antibiotics. Biofilm formation and phenotypic switching are among the most relevant adaptive 
biological processes. Triggering those processes bacteria have the potential to better survive to CF conditions and 
antibiotics action. Phenotypic switching provides a source of microbial diversity through switch between two 
phenotypic states, analogue to a mechanism ON/OFF, without the fitness costs of irreversible mutations. This 
interchange of states, visible by differential colony morphology, can have serious impact on bacterial virulence, 
antimicrobial resistance and persistence. 
The present work aims to investigate the specific colony variants-forming bacteria responsible by typical CF 
chronic infections. Through isolation and deep characterization of those colony variants, including 
discriminatory antibiotic susceptibility profiles and virulence characterization, it is intended to determine the 
mechanisms underlying the inefficiency of antimicrobial therapies of airway CF.  
P. aeruginosa strains (collection and clinical isolated) and LB medium were used to simulate airway CF 
infections. Clonal diversification of P. aeruginosa was checked after 24, 48, 72 and 120 hours after media 
inoculation (or initial infection) by colony morphology observation. The different colonies were further deep 
characterized in terms of resistance to in-use antibiotics including piperacillin (PRL), aztreonam (ATM), 
cefepime (FEP) and ceftazidime (CAZ) in Mueller-Hinton agar plates. Biofilm formation was also tested since it 
is one of the most relevant virulence factors in airway CF context. 
Data obtained revealed that new colony variants arisen according infection development stage. These new 
variants were generally more resistant than the normal P. aeruginosa colony morphology. Interestingly, the 
population were generally composed by colony variants with distinct resistance profiles. Some colony variants 
exhibited high specific resistance to CAZ, other variants to PRL or FEP. Some colony variants multi-resistant 
were as well observed. Such heterogeneous behaviours were also observed concerning biofilm formation ability. 
These results seemed to corroborate the “insurance hypothesis” that posits biodiversity as a mechanism to ensure 
population survival. In addition, data also highlight novel evidences since it was noted that single and well-
differentiated colonies seemed to encompass bacteria with distinct phenotypes. Such evidences emerged when a 
single colony was used to test its susceptibility and it was observed resistant mutants within the inhibition zones. 
The inclusion of resistant mutants was not exclusive of small colony variants, well known for its high and diverse 
antibiotic resistance. Several other colony morphologies showed to encompass resistant mutants in their 
populations. This evidence might revolutionize the actual colony morphology knowledge. Colony variants have 
been so far studied and considered as an amount of identical bacteria.  So, it is not just need the simple profiling 
of colony variants but the deep knowledge about bacteria that composed them. The ignorance or under 
valorisation of these mutants may be the reason of recalcitrance of CF infections. CF antimicrobial therapies 
must consider those mutants.
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